Cumberland Pharmaceuticals Inc. Stock News

Cumberland (CPIX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

NASHVILLE, Tenn., July 26, 2021 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, today released its 2020 Sustainability Report, which details the com

Jul.20 -- David Kotok, chairman and chief investment officer of Cumberland Advisors, discusses the opportunities he sees in the markets amid the Covid pandemic. He speaks with Haidi Stroud-Watts and S

John Rogers (Trades, Portfolio), leader of Ariel Investments, disclosed last week his firm made changes to its portfolio on June 30.

4 Small Drug Stocks Set to Escape the COVID-Led Industry Weakness

NASHVILLE, Tenn., June 21, 2021 /PRNewswire/ --Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, today released a series of case reports describing the effectiveness

Cumberland (CPIX) could produce exceptional returns because of its solid growth attributes.

NASHVILLE, Tenn., May 19, 2021 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, announced today that it has promoted John Hamm to  Director Financ

Cumberland Pharmaceuticals, Inc. (CPIX) CEO A. J. Kazimi on Q1 2021 Results - Earnings Call Transcript

Shares of Cumberland (NASDAQ:CPIX) moved higher in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased 600.00% over the past year to $0.07, which

NASHVILLE, Tenn., May 11, 2021 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, today is providing a company update and first quarter 2021 financial

Cumberland (NASDAQ:CPIX) announces its next round of earnings this Tuesday, May 11. Here is Benzinga's look at Cumberland's Q1 earnings report.

Seattle-based Tegria, a healthcare services and tech company that Providence launched last year, announced the acquisition of Franklin, Tenn.

Cumberland Pharmaceuticals, Inc. (CPIX) CEO A. J. Kazimi on Q4 2020 Results - Earnings Call Transcript

Cumberland (CPIX) delivered earnings and revenue surprises of 200.00% and 4.93%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?